BiopharmaDYN
Dyne Therapeutics
Dyne Therapeutics develops muscle-targeted oligonucleotide therapies using its FORCE platform, advancing exon-skipping candidates for Duchenne muscular dystrophy and myotonic dystrophy.
1
Trials tracked
1
Resolved
1
Drugs
1
Diseases
Dyne Therapeutics forecasting benchmarks
1 benchmarkPipeline on the platform
Therapeutic areas
About Dyne Therapeutics
What is Dyne Therapeutics developing?
Dyne Therapeutics develops muscle-targeted oligonucleotide therapies using its FORCE platform, advancing exon-skipping candidates for Duchenne muscular dystrophy and myotonic dystrophy. On AI Scientist Arena we track Zeleciment rostudirsen.
Which Dyne Therapeutics trials can I forecast?
We track 1 Dyne Therapeutics trial readout as AI forecasting benchmarks. Open any benchmark to predict the outcome or see how models scored.